viomedo Provides Access to Innovative Treatment Methods

viomedoInformation overload is a common and significant problem with most existing clinical trial search platforms or applications. viomedo makes clinical trial information easily accessible to everybody based on a variety of criteria and by following patient-centric approaches. So far, viomedo online platform aggregates about close to 2.000 clinical trials conducted in Germany.

viomedo's founder Alexander Puschilov mentioned: "We are convinced, that everybody has the right to get the best possible therapy! This is why we’ve built viomedo to help patients discover and benefit from innovative treatment methods that were previously accessible only to a few lucky patients."

viomedo's reported main functionality and features are:

  • The platform aggregates information about close to 2.000 open trials in Germany that are both investigator and industry initiated that cover most known diseases. Patients can find the trial with a convenient search by their disease name or select a disease from a list.
  • Patients see the trial’s most relevant information in a way that they can understand. That empowers them to decide independently if the trial is worth participating in.
  • Patients can contact the closest clinical trial site location conveniently via viomedo. After a personal screening interview with the investigator they can make an educated decision about their participation.

viomedo's team developed the platform using the input, requirements and the feedback of the patients enrolled in clinical trials and the suggestions and expectations of healthcare professionals. "We want to bring transparency into the field of clinical-studies in order to connect patients and providers," Puschilov says. "And there is definitely a need for patient-centered platforms like viomedo. The collected clinical trials information represented on the platform combined with the platform's usability frames makes viomedo the central, most advanced and ambitious focal point for clinical research in Germany."

For further information, please visit:
http://www.viomedo.de

About viomedo
viomedo is a free platform, which aggregates and interprets information about clinical trials online. It was founded by Alexander Puschilov, Stefan Nietert and Tim Seithe in 2015 in Berlin. They have deep expertise in the fields of technology, medicine and digital health. It covers close to 2.000 trials that are open to patients in Germany. Because viomedo solves a great problem for patients and researchers alike, it has gathered support from leading clinicians.

Most Popular Now

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...

Is AI in Medicine Playing Fair?

As artificial intelligence (AI) rapidly integrates into health care, a new study by researchers at the Icahn School of Medicine at Mount Sinai reveals that all generative AI models may...

Generative AI's Diagnostic Capabili…

The use of generative AI for diagnostics has attracted attention in the medical field and many research papers have been published on this topic. However, because the evaluation criteria were...

New System for the Early Detection of Au…

A team from the Human-Tech Institute-Universitat Politècnica de València has developed a new system for the early detection of Autism Spectrum Disorder (ASD) using virtual reality and artificial intelligence. The...

Diagnoses and Treatment Recommendations …

A new study led by Prof. Dan Zeltzer, a digital health expert from the Berglas School of Economics at Tel Aviv University, compared the quality of diagnostic and treatment recommendations...

AI Tool can Track Effectiveness of Multi…

A new artificial intelligence (AI) tool that can help interpret and assess how well treatments are working for patients with multiple sclerosis (MS) has been developed by UCL researchers. AI uses...

Surrey and Sussex Healthcare NHS Trust g…

Surrey and Sussex Healthcare NHS Trust has marked an important milestone in connecting busy radiologists across large parts of South East England, following the successful go live of Sectra's enterprise...

DMEA 2025 Ends with Record Attendance an…

8 - 10 April 2025, Berlin, Germany. DMEA 2025 came to a successful close with record attendance and an impressive program. 20,500 participants attended Europe's leading digital health event over the...

Dr Jason Broch Joins the Highland Market…

The Highland Marketing advisory board has welcomed a new member - Dr Jason Broch, a GP and director with a strong track record in the NHS and IT-enabled transformation. Dr Broch...

AI-Driven Smart Devices to Transform Hea…

AI-powered, internet-connected medical devices have the potential to revolutionise healthcare by enabling early disease detection, real-time patient monitoring, and personalised treatments, a new study suggests. They are already saving lives...

Multi-Resistance in Bacteria Predicted b…

An AI model trained on large amounts of genetic data can predict whether bacteria will become antibiotic-resistant. The new study shows that antibiotic resistance is more easily transmitted between genetically...